029-83533393
   info@TaiBSbio.com
 
组织芯片，组织微阵列
多器官
头颈部
口腔
软组织(肌肉脂肪血管等)
皮肤
黑色素瘤
淋巴瘤
脑
心脏
鼻咽和喉
肺
骨和软骨
骨髓
食道
胃
小肠
结肠
直肠
肝
胰腺
阑尾
肾脏
尿道膀胱
甲状腺
肾上腺
胸腺
淋巴结
脾
乳腺
卵巢
输卵管
子宫及内膜
子宫颈
外阴 (阴唇)
前列腺
睾丸
阴茎
间皮
转移癌
胚胎瘤
胎儿
寄生虫
猴子 -恒河猴
猴子 -食蟹猴,
狗
大鼠
小鼠
其它
免疫系统
 
RLN10011肺非小细胞癌及肺组织组合芯片，附病理分级、TNM和临床分期，50例/100点
点 数100例 数50
行 数10列 数10
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.
产品名:RLN10011
 
肺非小细胞癌及肺组织组合微阵列芯片，包含24例鳞状细胞癌，16例腺癌，10例肺组织，一例两点，分成两个相同的小方阵（2x50点）
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Lun
-Lung
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Normal (*)
TISSUE  ARRAYS RLN10011
1
2
3
4
5
6
7
8
9
10
A
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
B
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
C
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
D
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
E
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
F
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
G
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
H
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
I
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
J
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1163MLungSquamous cell carcinoma with necrosis1T2N0M0IBMalignant5*4*3.5N
A2253MLungSquamous cell carcinoma1T2N0M0IBMalignant3*3*3N
A3330MLungSquamous cell carcinoma1--2T2aN0M0IBMalignant4.5*4*3N
A4445MLungSquamous cell carcinoma2T4N1M0IIIAMalignant*N
A5555MLungSquamous cell carcinoma with necrosis2T2bN0M0IIAMalignant5.5*4*3.5N
A6663MLungSquamous cell carcinoma with necrosis1T2N0M0IBMalignant5*4*3.5N
A7753MLungSquamous cell carcinoma1T2N0M0IBMalignant3*3*3N
A8830MLungSquamous cell carcinoma1--2T2aN0M0IBMalignant4.5*4*3N
A9945MLungSquamous cell carcinoma2T4N1M0IIIAMalignant*N
A101055MLungSquamous cell carcinoma2T2bN0M0IIAMalignant5.5*4*3.5N
B11162MLungSquamous cell carcinoma2T2bN1M0IIBMalignant*N
B21250MLungSquamous cell carcinoma2T2aN1M0IIBMalignant5*4*4N
B31363MLungSquamous cell carcinoma2T2bN0M0IIAMalignant*N
B41460MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant*N
B51563MLungSquamous cell carcinoma2T2N1M0IIBMalignant*N
B61662MLungSquamous cell carcinoma2T2bN1M0IIBMalignant*N
B71750MLungSquamous cell carcinoma with necrosis2T2aN1M0IIBMalignant5*4*4N
B81863MLungSquamous cell carcinoma with necrosis2T2bN0M0IIAMalignant*N
B91960MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant*N
B102063MLungSquamous cell carcinoma with necrosis2T2N1M0IIBMalignant*N
C12163FLungSquamous cell carcinoma2T1N0M0IMalignant1.5*1.5*1N
C22269MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant6*5*4N
C32365MLungSquamous cell carcinoma with necrosis2T2aN0M0IBMalignant*N
C42472MLungSquamous cell carcinoma2T2N1M0IIBMalignant7*3*1.5N
C52546MLungSquamous cell carcinoma with necrosis2T3N1M0IIIAMalignant*N
C62663FLungSquamous cell carcinoma2T1N0M0IMalignant1.5*1.5*1N
C72769MLungSquamous cell carcinoma2T2N0M0IBMalignant6*5*4N
C82865MLungSquamous cell carcinoma with necrosis2T2aN0M0IBMalignant*N
C92972MLungSquamous cell carcinoma2T2N1M0IIBMalignant7*3*1.5N
C103046MLungSquamous cell carcinoma2T3N1M0IIIAMalignant*N
D13153MLungSquamous cell carcinoma with necrosis3T1N1M0IIBMalignant*N
D23262MLungSquamous cell carcinoma3T2aN1M0IIBMalignant5*5*4N
D33335MLungSquamous cell carcinoma3T1bN0M0IAMalignant3*3*2N
D43452MLungSquamous cell carcinoma3T2bN1M0IIBMalignant*N
D53563MLungSquamous cell carcinoma3T2bN1M0IIBMalignant*N
D63653MLungSquamous cell carcinoma3T1N1M0IIBMalignant*N
D73762MLungSquamous cell carcinoma3T2aN1M0IIBMalignant5*5*4N
D83835MLungSquamous cell carcinoma with necrosis3T1bN0M0IAMalignant3*3*2N
D93952MLungSquamous cell carcinoma with necrosis3T2bN1M0IIBMalignant*N
D104063MLungSquamous cell carcinoma3T2bN1M0IIBMalignant*N
E14167MLungSquamous cell carcinoma3T2bN1M0IIBMalignant7*6*6N
E24268MLungSquamous cell carcinoma3T4N1M0IIIAMalignant8*7*5N
E34370MLungSquamous cell carcinoma with necrosis3T2aN0M0IBMalignant*N
E44441MLungSquamous cell carcinoma3T2N0M0IBMalignant4*3*2N
E54549MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*4.0*3.0N
E64667MLungSquamous cell carcinoma3T2bN1M0IIBMalignant7*6*6N
E74768MLungSquamous cell carcinoma3T4N1M0IIIAMalignant8*7*5N
E84870MLungSquamous cell carcinoma3T2aN0M0IBMalignant*N
E94941MLungSquamous cell carcinoma3T2N0M0IBMalignant4*3*2N
E105049MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*4.0*3.0N
F15158FLungAdenocarcinoma with necrosis2T2bN1M0IIBMalignant6.5*5.0*4.5N
F25248FLungAdenocarcinoma2T2N0M0IBMalignant*N
F35359MLungAdenocarcinoma2T2bN0M0IIAMalignant*N
F45467MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*2.5*2.0N
F55542MLungAdenocarcinoma2T2N0M0IBMalignant*N
F65658FLungAdenocarcinoma2T2bN1M0IIBMalignant6.5*5.0*4.5N
F75748FLungAdenocarcinoma2T2N0M0IBMalignant*N
F85859MLungAdenocarcinoma2T2bN0M0IIAMalignant*N
F95967MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*2.5*2.0N
F106042MLungAdenocarcinoma with necrosis2T2N0M0IBMalignant*N
G16162MLungAdenocarcinoma2T2aN0M0IBMalignant4.5*4.0*3.0N
G26254MLungAdenocarcinoma2T3N1M0IIIAMalignant8*6.5*6N
G36354MLungAdenocarcinoma2T2bN2M0IIIAMalignant4.0*4.0*2.5N
G46465MLungAdenocarcinoma with necrosis2T2aN2M0IIIAMalignant5.0*5.0*3.5N
G56539FLungAdenocarcinoma2T2aN0M0IBMalignant*N
G66662MLungAdenocarcinoma2T2aN0M0IBMalignant4.5*4.0*3N
G76754MLungAdenocarcinoma2T3N1M0IIIAMalignant8*6.5*6N
G86854MLungAdenocarcinoma2T2bN2M0IIIAMalignant4.0*4.0*2.5N
G96965MLungAdenocarcinoma2T2aN2M0IIIAMalignant5.0*5.0*3.5N
G107039FLungAdenocarcinoma with necrosis2T2aN0M0IBMalignant*N
H17158MLungAdenocarcinoma with necrosis2T2bN0M0IIAMalignant5.0*4.0*4N
H27248MLungInvasive adenocarcinoma2T2N1M0IIBMalignant*N
H37365MLungAdenocarcinoma2T2bN0M0IIAMalignant7.5*5.0*4N
H47465FLungAdenocarcinoma with necrosis2T2bN2M0IIIAMalignant*N
H57561MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*3.5*3.0N
H67658MLungAdenocarcinoma2T2bN0M0IIAMalignant5.0*4.0*4N
H77748MLungInvasive adenocarcinoma with necrosis2T2N1M0IIBMalignant*N
H87865MLungAdenocarcinoma2T2bN0M0IIAMalignant7.5*5.0*4N
H97965FLungAdenocarcinoma2T2bN2M0IIIAMalignant*N
H108061MLungAdenocarcinoma2T2aN0M0IBMalignant4.0*3.5*3.0N
I18147MLungLung tissue (chronic inflammation)***Normal*N
I28224MLungLung tissue (chronic inflammation)***Normal*N
I38325FLungLung tissue (chronic inflammation)***Normal*N
I48419MLungLung tissue (chronic inflammation)***Normal*N
I58555MLungLung tissue***Normal*N
I68647MLungLung tissue***Normal*N
I78724MLungLung tissue (chronic inflammation)***Normal*N
I88825FLungLung tissue (chronic inflammation)***Normal*N
I98919MLungLung tissue (chronic inflammation)***Normal*N
I109055MLungLung tissue***Normal*N
J19145FLungLung tissue (chronic inflammation)***Normal*N
J29248MLungLung tissue (chronic inflammation)***Normal*N
J39330MLungLung tissue (chronic inflammation)***Normal*N
J49443MLungLung tissue***Normal*N
J59540FLungLung tissue***Normal*N
J69645FLungLung tissue***Normal*N
J79748MLungLung tissue (chronic inflammation)***Normal*N
J89830MLungLung tissue***Normal*N
J99943MLungLung tissue (chronic inflammation)***Normal*N
J1010040FLungLung tissue***Normal*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址：陕西西安市灞桥区长乐东路2999号
电话：029-83533393, 17792711553,
电子邮箱：taibsbio@163.com
QQ:3144647811
微信号：13002913390
邮政编码：710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售，加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队，并且具有庞大的组织标本库。样本库中组织微阵列种类多，病理类型齐全，同时根据客户需求情况进行制作加工新的组织微阵列，尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度，致力于为广大客户提供质量好的产品和优质的服务。

更多详情